Bacuyong, Juanito, Jr. S.
HRN: 21-95-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
10/29/2022
11/04/2022
IV
750mg
OD
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes